跳至主要内容
临床试验/PACTR202003901399017
PACTR202003901399017尚未招募4 期

Pilot trial to examine the feasibility, acceptability, and impact on longer-term adherence of an intervention using a new urine-based tenofovir adherence assay

niversity of California San Fransisco0 个研究点目标入组 100 人开始时间: 2020年3月12日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
Female

入选标准

  • The eligibility criteria for this study are the following:
  • Adult, age =18 years old
  • HIV-1 uninfected based on a negative HIV-1 rapid test
  • Not currently enrolled in an HIV-1 prevention clinical trial
  • Not currently in a serodiscordant relationship
  • Already taking PrEP and will be enrolled at the 3-month follow-up visit following PrEP initiation
  • Willing to be randomized to point-of-care tenofovir drug testing
  • Willing/able to provide informed consent to participate in the study
  • No contraindication to use of TDF or FTC
  • Note: Women who are pregnant at screening/enrollment are still eligible

排除标准

  • Not willing and/or not able to provide written informed consent to participate in the study
  • In a HIV serodiscordant relationship
  • Not willing to be randomized to either arms of the study

研究者

发起方
niversity of California San Fransisco

相似试验